{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:28:15Z","timestamp":1793975295574,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2022GCZX02"],"award-info":[{"award-number":["2022GCZX02"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Provincial Medical Research Foundation","doi-asserted-by":"publisher","award":["A2024632"],"award-info":[{"award-number":["A2024632"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbrep.2026.102806","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:06:13Z","timestamp":1791839173000},"page":"102806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TPPU, a soluble epoxide hydrolase inhibitor, mitigates A\u03b2-induced neurotoxicity via dual modulation of mitochondrial stabilization and JNK suppression"],"prefix":"10.1016","volume":"48","author":[{"given":"Jingfang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102806_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","article-title":"Mechanisms of pathogenic tau and abeta protein spreading in Alzheimer's disease","volume":"12","author":"d'Errico","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-180802","article-title":"Understanding the amyloid hypothesis in Alzheimer's disease","volume":"68","author":"Paroni","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrep.2026.102806_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrep.2026.102806_bib4","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.bbrep.2026.102806_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrep.2026.102806_bib6","article-title":"Abeta plaques","author":"Walker","year":"2020","journal-title":"Free Neuropathol. 1"},{"key":"10.1016\/j.bbrep.2026.102806_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126355","article-title":"Neurotoxic soluble amyloid oligomers drive alzheimer's pathogenesis and represent a clinically validated target for slowing disease progression","volume":"22","author":"Tolar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102806_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fnins.2018.00963","article-title":"Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer's disease","volume":"12","author":"Marttinen","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib9","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/pro.3906","article-title":"Progress toward Alzheimer's disease treatment: leveraging the Achilles' heel of Abeta oligomers?","volume":"29","author":"Fantini","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrep.2026.102806_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167617","article-title":"Mitochondria-targeting by small molecules against Alzheimer's disease: a mechanistic perspective","volume":"1871","author":"Pal","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrep.2026.102806_bib11","article-title":"The molecular mechanisms of neuroinflammation in Alzheimer's disease, the consequence of neural cell death","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102806_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/br.2017.863","article-title":"Role of amyloid beta protein receptors in mediating synaptic plasticity","volume":"6","author":"Li","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.bbrep.2026.102806_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149019","article-title":"Neuroprotective effect of emodin on Abeta(25-35)-induced cytotoxicity in PC12 cells involves Nrf2\/GPX4 and TLR4\/p-NF-kappaB\/NLRP3 pathways","volume":"1841","author":"Xia","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2026.102806_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2014.09.003","article-title":"Role of soluble epoxide hydrolase in age-related vascular cognitive decline","volume":"113\u2013115","author":"Nelson","year":"2014","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.bbrep.2026.102806_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrep.2026.102806_bib16","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","article-title":"Hepatic soluble epoxide hydrolase activity regulates cerebral Abeta metabolism and the pathogenesis of Alzheimer's disease in mice","volume":"111","author":"Wu","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.bbrep.2026.102806_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.apha.2022.12.004","article-title":"Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway","volume":"97","author":"Fromel","year":"2023","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102806_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14511","article-title":"Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: insights for Alzheimer's disease therapeutics","volume":"30","author":"Grinan-Ferre","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbrep.2026.102806_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1206","article-title":"An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease","volume":"12","author":"Ghosh","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrep.2026.102806_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/cjp.cjp_80_21","article-title":"Epoxyeicosatrienoic acids and soluble epoxide hydrolase in physiology and diseases of the central nervous system","volume":"65","author":"Kuo","year":"2022","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.bbrep.2026.102806_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","article-title":"Soluble epoxide hydrolase and brain cholesterol metabolism","volume":"12","author":"Domingues","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/alz.12370","article-title":"Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases","volume":"18","author":"Zhao","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.bbrep.2026.102806_bib23","first-page":"1524","article-title":"JNK activation in Alzheimer's disease is driven by amyloid beta and is associated with Tau pathology","volume":"14","author":"Solas","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/153331750201700209","article-title":"The JNK\/c-Jun cascade and Alzheimer's disease","volume":"17","author":"Okazawa","year":"2002","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.bbrep.2026.102806_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12031-010-9454-6","article-title":"JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities","volume":"43","author":"Mehan","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbadis.2014.05.012","article-title":"Mitochondrial JNK activation triggers autophagy and apoptosis and aggravates myocardial injury following ischemia\/reperfusion","volume":"1852","author":"Xu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2026.102806_bib27","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/onc.2008.301","article-title":"JNK signaling in apoptosis","volume":"27","author":"Dhanasekaran","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2026.102806_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00355-6","article-title":"JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis","volume":"38","author":"Putcha","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbrep.2026.102806_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neulet.2004.02.041","article-title":"Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain","volume":"361","author":"Waetzig","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrep.2026.102806_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2003.10.034","article-title":"c-Jun N-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia","volume":"146","author":"Wang","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrep.2026.102806_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(98)00751-4","article-title":"Activation of c-jun N-terminal kinase\/stress-activated protein kinase and the decreased ratio of Bcl-2 to Bax are associated with the auto-oxidized dopamine-induced apoptosis in PC12 cells","volume":"256","author":"Kang","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrep.2026.102806_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105957","article-title":"1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea exerts neuro-protective effects against ischemic injury via suppressing JNK\/p38 MAPK-mediated mitochondrial apoptosis pathway","volume":"30","author":"Yi","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.bbrep.2026.102806_bib33","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1152\/ajprenal.00052.2022","article-title":"Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy","volume":"324","author":"Noh","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrep.2026.102806_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrn3729","article-title":"Nuclear and cytosolic JNK signalling in neurons","volume":"15","author":"Coffey","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102806_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062433","article-title":"A soluble epoxide hydrolase inhibitor improves cerebrovascular dysfunction, neuroinflammation, amyloid burden, and cognitive impairments in the hAPP\/PS1 TgF344-AD rat model of Alzheimer's disease","volume":"26","author":"Fang","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:05:31Z","timestamp":1793973931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826003663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"alternative-id":["S2405580826003663"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102806","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TPPU, a soluble epoxide hydrolase inhibitor, mitigates A\u03b2-induced neurotoxicity via dual modulation of mitochondrial stabilization and JNK suppression","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102806"}}